Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma"

H. Sasaki, M. C. Zlatescu, Rebecca Betensky, L. B. Johnk, A. N. Cutone, J. G. Cairncross, D. N. Louis

Research output: Contribution to journalArticle

Abstract

Allelic loss of chromosome 1p predicts increased chemosensitivity and better survival in oligodendroglial tumors. Clinical testing for 1p loss in oligodendroglial tumors at our hospital has allowed us to postulate that certain histological appearances are associated with 1p allelic status. Forty-four cases received for genetic testing were diagnosed by referring pathologists as pure low-grade oligodendroglioma. Central neuropathological review divided the series equally into 22 cases with classical oligodendroglioma histology and 22 with more astrocytic features. Molecular genetic analyses demonstrated 1p loss in 19 of 22 classic oligodendrogliomas (86%) and maintenance of both 1p alleles in 16 of 22 gliomas with astrocytic features (73%). No glial fibrillary acidic protein-positive cell type (gliofibrillary oligodendrocyte, minigemistocyte, cellular processes) was associated with 1p allelic status. Fourteen of the 44 cases were treated with chemotherapy at tumor progression: 3 "astrocytic" gliomas with 1p loss responded to PCV chemotherapy and 2 classic oligodendrogliomas that maintained both 1p alleles included a responder and a non-responder. These results suggest that histological appearance correctly predicts genotype in approximately 80% of low-grade gliomas, but that tumor genotype more closely predicts chemosensitivity. As a result, such objective molecular genetic analyses should be incorporated into patient management and into clinical trials of low-grade diffuse gliomas.

Original languageEnglish (US)
Pages (from-to)58-63
Number of pages6
JournalJournal of Neuropathology and Experimental Neurology
Volume61
Issue number1
DOIs
StatePublished - Jan 1 2002

Fingerprint

Oligodendroglioma
Molecular Biology
Referral and Consultation
Astrocytoma
Glioma
Neoplasms
Alleles
Genotype
Drug Therapy
Loss of Heterozygosity
Glial Fibrillary Acidic Protein
Oligodendroglia
Genetic Testing
Histology
Chromosomes
Maintenance
Clinical Trials
Survival
Pathologists

Keywords

  • Astrocytoma
  • Chromosome 19q
  • Chromosome 1p
  • GFAP
  • Histopathology
  • Oligodendroglioma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma". / Sasaki, H.; Zlatescu, M. C.; Betensky, Rebecca; Johnk, L. B.; Cutone, A. N.; Cairncross, J. G.; Louis, D. N.

In: Journal of Neuropathology and Experimental Neurology, Vol. 61, No. 1, 01.01.2002, p. 58-63.

Research output: Contribution to journalArticle

Sasaki, H. ; Zlatescu, M. C. ; Betensky, Rebecca ; Johnk, L. B. ; Cutone, A. N. ; Cairncross, J. G. ; Louis, D. N. / Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma". In: Journal of Neuropathology and Experimental Neurology. 2002 ; Vol. 61, No. 1. pp. 58-63.
@article{f47de073335c46e385b96f68b966de26,
title = "Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade {"}oligodendroglioma{"}",
abstract = "Allelic loss of chromosome 1p predicts increased chemosensitivity and better survival in oligodendroglial tumors. Clinical testing for 1p loss in oligodendroglial tumors at our hospital has allowed us to postulate that certain histological appearances are associated with 1p allelic status. Forty-four cases received for genetic testing were diagnosed by referring pathologists as pure low-grade oligodendroglioma. Central neuropathological review divided the series equally into 22 cases with classical oligodendroglioma histology and 22 with more astrocytic features. Molecular genetic analyses demonstrated 1p loss in 19 of 22 classic oligodendrogliomas (86{\%}) and maintenance of both 1p alleles in 16 of 22 gliomas with astrocytic features (73{\%}). No glial fibrillary acidic protein-positive cell type (gliofibrillary oligodendrocyte, minigemistocyte, cellular processes) was associated with 1p allelic status. Fourteen of the 44 cases were treated with chemotherapy at tumor progression: 3 {"}astrocytic{"} gliomas with 1p loss responded to PCV chemotherapy and 2 classic oligodendrogliomas that maintained both 1p alleles included a responder and a non-responder. These results suggest that histological appearance correctly predicts genotype in approximately 80{\%} of low-grade gliomas, but that tumor genotype more closely predicts chemosensitivity. As a result, such objective molecular genetic analyses should be incorporated into patient management and into clinical trials of low-grade diffuse gliomas.",
keywords = "Astrocytoma, Chromosome 19q, Chromosome 1p, GFAP, Histopathology, Oligodendroglioma",
author = "H. Sasaki and Zlatescu, {M. C.} and Rebecca Betensky and Johnk, {L. B.} and Cutone, {A. N.} and Cairncross, {J. G.} and Louis, {D. N.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1093/jnen/61.1.58",
language = "English (US)",
volume = "61",
pages = "58--63",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma"

AU - Sasaki, H.

AU - Zlatescu, M. C.

AU - Betensky, Rebecca

AU - Johnk, L. B.

AU - Cutone, A. N.

AU - Cairncross, J. G.

AU - Louis, D. N.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Allelic loss of chromosome 1p predicts increased chemosensitivity and better survival in oligodendroglial tumors. Clinical testing for 1p loss in oligodendroglial tumors at our hospital has allowed us to postulate that certain histological appearances are associated with 1p allelic status. Forty-four cases received for genetic testing were diagnosed by referring pathologists as pure low-grade oligodendroglioma. Central neuropathological review divided the series equally into 22 cases with classical oligodendroglioma histology and 22 with more astrocytic features. Molecular genetic analyses demonstrated 1p loss in 19 of 22 classic oligodendrogliomas (86%) and maintenance of both 1p alleles in 16 of 22 gliomas with astrocytic features (73%). No glial fibrillary acidic protein-positive cell type (gliofibrillary oligodendrocyte, minigemistocyte, cellular processes) was associated with 1p allelic status. Fourteen of the 44 cases were treated with chemotherapy at tumor progression: 3 "astrocytic" gliomas with 1p loss responded to PCV chemotherapy and 2 classic oligodendrogliomas that maintained both 1p alleles included a responder and a non-responder. These results suggest that histological appearance correctly predicts genotype in approximately 80% of low-grade gliomas, but that tumor genotype more closely predicts chemosensitivity. As a result, such objective molecular genetic analyses should be incorporated into patient management and into clinical trials of low-grade diffuse gliomas.

AB - Allelic loss of chromosome 1p predicts increased chemosensitivity and better survival in oligodendroglial tumors. Clinical testing for 1p loss in oligodendroglial tumors at our hospital has allowed us to postulate that certain histological appearances are associated with 1p allelic status. Forty-four cases received for genetic testing were diagnosed by referring pathologists as pure low-grade oligodendroglioma. Central neuropathological review divided the series equally into 22 cases with classical oligodendroglioma histology and 22 with more astrocytic features. Molecular genetic analyses demonstrated 1p loss in 19 of 22 classic oligodendrogliomas (86%) and maintenance of both 1p alleles in 16 of 22 gliomas with astrocytic features (73%). No glial fibrillary acidic protein-positive cell type (gliofibrillary oligodendrocyte, minigemistocyte, cellular processes) was associated with 1p allelic status. Fourteen of the 44 cases were treated with chemotherapy at tumor progression: 3 "astrocytic" gliomas with 1p loss responded to PCV chemotherapy and 2 classic oligodendrogliomas that maintained both 1p alleles included a responder and a non-responder. These results suggest that histological appearance correctly predicts genotype in approximately 80% of low-grade gliomas, but that tumor genotype more closely predicts chemosensitivity. As a result, such objective molecular genetic analyses should be incorporated into patient management and into clinical trials of low-grade diffuse gliomas.

KW - Astrocytoma

KW - Chromosome 19q

KW - Chromosome 1p

KW - GFAP

KW - Histopathology

KW - Oligodendroglioma

UR - http://www.scopus.com/inward/record.url?scp=0036136919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036136919&partnerID=8YFLogxK

U2 - 10.1093/jnen/61.1.58

DO - 10.1093/jnen/61.1.58

M3 - Article

VL - 61

SP - 58

EP - 63

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 1

ER -